Learn more

IMPACT THERAPEUTICS INC

Overview
  • Total Patents
    71
  • GoodIP Patent Rank
    34,227
  • Filing trend
    ⇩ 13.0%
About

IMPACT THERAPEUTICS INC has a total of 71 patent applications. It decreased the IP activity by 13.0%. Its first patent ever was published in 2010. It filed its patents most often in WIPO (World Intellectual Property Organization), China and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are SHIJIAZHUANG SAGACITY NEW DRUG DEV CO LTD, GPI NIL HOLDINGS and HEXAPHARMATEC CO LTD.

Patent filings per year

Chart showing IMPACT THERAPEUTICS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Tian Ye Edward 53
#2 Cai Suixiong 39
#3 Cai Sui Xiong 29
#4 Yin Feng 24
#5 Liu Lijun 21
#6 Kang Sishun 20
#7 Wu Lizhen 20
#8 Gu Chengyun 20
#9 Chen Shengzhi 19
#10 Wang Xiaozhu 18

Latest patents

Publication Filing date Title
WO2021073491A1 Dihydroimidazo pyrimido pyrimidinone compound
WO2021047646A1 Substituted imidazoquinoxaline compounds and uses thereof
WO2021043208A1 3, 5-disubstituted pyrazole compounds as kinase inhibitors and uses thereof
WO2021004482A1 Substituted pyrazoloquinazolone compound and application thereof
WO2020259601A1 Substituted fused heteroaromatic bicyclic compounds as kinase inhibitors and the use thereof
US2020131192A1 IMIDAZO[1,2-b]PYRIMIDO[4,5-d]PYRIDAZIN-5(6H)-ONES AND THE USE THEREOF
CN110312717A The condensed heteroaryl tricyclic compound replaced is as kinase inhibitor and its application
AU2018206111A1 Substituted fused heteroaryl compound serving as a kinase inhibitor, and applications thereof
AU2017359844A1 8,9-dihydroimidazole[1,2-a]pyrimido[5,4-e]pyrimidine-5(6H)-ketone compound
CN109890390A Application of the Hedgehog pathway inhibitor in treatment fibrotic disease
WO2017167251A1 Manufacturing process for 1-(arylmethyl) quinazoline-2,4 (1h, 3h)-dione
AU2016239141A1 Solid pharmaceutical formulation of PARP inhibitors and the use thereof
CN103570625A N-(3-aryl-heteroaryl)-4-aryl-aryl carboxamide and analog as hedgehog pathway inhibitors and application thereof
CN104066723A 1-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs and the use thereof
WO2013013614A1 4-(3-heteroarylarylamino)quinazoline and 1-(3-heteroarylarylamino)isoquinoline as hedgehog pathway inhibitor and use thereof
WO2012159565A1 6-(aryl-carboxamide) imidazo [1,2-a] pyrimidine and 6-(aryl carboxamide) [1,2,4] triazolo [4,3-a] pyrimidine as hedgehog pathway inhibitor and use thereof
TW201245161A 1-(arylmethyl)quinazoline-2,4(1h,3h)-diones as parp inhibitors and the use thereof
CN103370316A 3-aryl-6-aryl-[1,2,4]triazolo[4,3-a]pyridines as inhibitors of cell proliferation and the use thereof
CN102020648A 3-aryl-6-aryl-[1,2,4] triazol [4,3-b] pyridazine taken as cell proliferation inhibitor and application of cell proliferation inhibitor
WO2012065297A1 3-ARYL-6-ARYL-[1,2,4]TRIAZOLO[4,3-a]PYRIDINES AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF